Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

(BSX, UGI, ABH, CRWE) Stock in Review by

Stock-PR Reporting



FREE Daily Stock Alerts From




Boston Scientific Corporation (NYSE:BSX) issued the following statement from John Pedersen, Senior Vice President and President of the Company's Urology and Women's Health Division, following the conclusion of a two-day meeting of the U.S. Food and Drug Administration (FDA) Obstetrics & Gynecology Devices Advisory Committee. During the meeting, the Committee heard presentations on the safety, effectiveness and continued classification of surgical mesh as a Class II device to repair pelvic organ prolapse (POP) and stress urinary incontinence (NYSE:SUI) in women.

Read more at :